WO2011154421A1 - Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique - Google Patents

Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique Download PDF

Info

Publication number
WO2011154421A1
WO2011154421A1 PCT/EP2011/059423 EP2011059423W WO2011154421A1 WO 2011154421 A1 WO2011154421 A1 WO 2011154421A1 EP 2011059423 W EP2011059423 W EP 2011059423W WO 2011154421 A1 WO2011154421 A1 WO 2011154421A1
Authority
WO
WIPO (PCT)
Prior art keywords
water
microcapsules
core
soluble
shell
Prior art date
Application number
PCT/EP2011/059423
Other languages
German (de)
English (en)
Inventor
Jing Dreher
Matthias Laubender
Michael Kutschera
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2011154421A1 publication Critical patent/WO2011154421A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • B01J13/18—In situ polymerisation with all reactants being present in the same phase
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A61K8/0279—Porous; Hollow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
    • C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • C11D3/502—Protected perfumes
    • C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/12—Processes in which the treating agent is incorporated in microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5115—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes

Definitions

  • the present invention relates to microcapsules having a core-shell structure containing at least one low molecular weight, anionic surfactant and having a metal oxide-containing shell, a process for producing such microcapsules having a core-shell structure , the use of microcapsules with the core-shell construction and preparations containing the microcapsules with the core-shell construction.
  • the encapsulation of drugs is done for a variety of reasons.
  • the encapsulation can increase the storage stability of those substances that are sensitive to light, oxygen or moisture.
  • the encapsulation can specifically influence the release of active ingredient.
  • liquid substances can be handled after encapsulation in the form of a free-flowing powder.
  • the encapsulation of flavorings, flavors or fragrances serves firstly to prevent a reaction of these encapsulated substances with atmospheric oxygen or other chemicals present in the formulations, such as, for example, bleaching agents.
  • fragrances or fragrances Another problem is the sometimes high volatility of the fragrances or fragrances, which means that a large part of the originally added to the detergent or cleaning agent fragrance or fragrance has volatilized before the date of use.
  • WO 2005/009604 A1 describes microcapsules with a high active ingredient content, in which a core containing an active substance is enveloped by a shell, wherein the shell comprises an inorganic polymer.
  • capsules which exhibit improved stability against accidental rupture of the shell or which have a denser, less porous shell to prevent leakage or volatilization of the active agent.
  • the shell must not be so stable that a release of fragrances or fragrances under normal mechanical stress hardly or not at all takes place.
  • the capsules should contain no unwanted by-products, such as residues of unreacted monomers.
  • the process for the preparation of the capsules should be as widely used and easy to carry out. The process for making the capsules should be stable to both thermal and mechanical stresses.
  • the object of the present invention was therefore to provide active ingredient-containing capsules with improved stability with regard to the protection of the active ingredient against undesirable volatilization and to be able to produce the novel active ingredient-containing capsules by a simple and robust process.
  • microcapsules having a core-shell structure containing at least one low molecular weight anionic surfactant, wherein each microcapsule internally contains a core containing at least one sparingly water-soluble or water-insoluble organic active substance and a shell directly around the core. has, wherein the shell comprises at least one metal oxide and at least one water-soluble polymer dissolved.
  • the mass fraction of the core in relation to the total mass of the microcapsules according to the invention is usually greater than 10% by weight, preferably greater than 20% by weight, particularly preferably in the range from 25 to 80% by weight, very particularly preferably in the range from From 30 to 60% by weight.
  • the percentages refer to a statistical average determined over a large number of microcapsules.
  • the microcapsules according to the invention having a core-shell structure each contain a core in the interior which comprises at least one organic substance which is sparingly soluble in water or insoluble in water.
  • the core can be both liquid and solid at 20 ° C. If the core is a solid at 20 ° C, this solid may be crystalline, semi-crystalline or amorphous. If the core is a liquid at 20 ° C, this liquid may be a homogeneous phase or a suspension.
  • the core of the microcapsules according to the invention is preferably a liquid at 20 ° C.
  • the core in the interior of the microcapsules according to the invention often contains, in addition to the at least one sparingly water-soluble or water-insoluble organic active ingredient, at least one sparingly water-soluble or water-insoluble organic adjuvant, for example for concentration of the active ingredient, for altering the release profile of the active ingredient or simply for dissolving or suspending the Active ingredient serves. Therefore, the concentration of the active ingredient in the core of the microcapsules according to the invention can be varied over a wide range according to the field of use and the properties of the active ingredient, such as its solubility in the organic adjuvant.
  • the core preferably exhibits hydrophobic properties, that is to say that the core is only sparingly water-soluble or water-insoluble.
  • the microcapsules according to the invention usually have an average particle size (d 50 value) of less than 100 ⁇ m, preferably less than 10 ⁇ m, particularly preferably an average particle size of from 0.05 ⁇ m to 5 ⁇ m, in particular from 0.1 ⁇ m to 2 ⁇ m ,
  • the d50 value is defined by that 50% by weight of the particles have a diameter smaller and 50% by weight of the particles have a diameter greater than the value corresponding to the d50 value.
  • the d50 value can be read off from a particle size distribution curve, such as can be generated, for example, by means of light scattering in accordance with ISO 13320-1 (for example Microtrac S3500 Bluewave from Microtrac).
  • microcapsules according to the invention particularly preferably have an average particle size of less than 2 ⁇ m.
  • the average particle size of the microcapsules and the thickness of the shells can be determined by means of TEM (transmission electron microscopy).
  • the average particle size can be determined by the methods of light scattering (static and dynamic light scattering).
  • the shape of the cores in the microcapsules according to the invention is arbitrary and may be, for example, irregular or spherical, preferably spherical.
  • microcapsules of the invention having a core-shell structure contain at least one low molecular weight, anionic surfactant, the molar mass of the low molecular weight, anionic surfactants usually being less than 1000 g / mol, preferably less than 500 g / mol.
  • Anionic surfactants have, in addition to a nonpolar, fat-soluble part, a polar, negatively charged part, such as a carboxylate radical, a sulfonate radical, a sulfate radical or a phosphate radical.
  • Typical representatives for low Examples of molecular anionic surfactants are alkylcarboxylates, alkylbenzenesulfonates, secondary alkanesulfonates, alkylphenol sulfate or fatty alcohol sulfates.
  • Typical representatives for the various classes of anionic surfactants are listed in WO 2009/090169, page 10, line 37 to page 12, line 6.
  • Particularly preferred are microcapsules in which the low molecular weight, anionic surfactant is a fatty alcohol sulfate or an alkylphenol ether sulfate.
  • the salts of the preferred fatty alcohol sulfates have the formula: C n H 2n + iOS03 ⁇ M + n is from 8 to 18, in particular 10 to 16, and M is Na or K, in particular Na.
  • the microcapsules according to the invention having a core-shell structure additionally contain at least one nonionic surfactant in addition to the at least one low molecular weight, anionic surfactant.
  • Nonionic surfactants are surface-active substances with an uncharged, in the neutral pH range no ion charge-carrying, polar, hydrophilic, water-solubilizing head group (in contrast to anionic see and cationic surfactants) adsorbed at interfaces and above the critical micelle concentration (eme) to aggregated to neutral micelles.
  • oligo oxyalkylene groups in particular (oligo) oxyethylene groups (polyethylene glycol groups), including the fatty alcohol polyglycol ethers, fatty alcohols, alkylphenol polyglycol ethers, fatty acid ethoxylates, alkoxylated triglycerides and mixed ethers (alkylated on both sides).
  • ethylene glycol ethers ethylene glycol ethers
  • carbohydrate groups which include, for.
  • alkyl polyglucosides and fatty acid N-methylglucamide count are listed in WO 2009/090169, page 13, line 17 to page 15, line 9.
  • nonionic surfactants are sorbitan fatty acid esters with poly- ethylenglycolresten, so-called polysorbates (Tween ® types), such as polyvinyl lyoxyethylen (20) sorbitan monolaurate.
  • the proportion by weight of the surfactants used, based on the mass of the oil phase is preferably in the range from 0.5% to 20%, in particular in the range from 1% to 5%.
  • sparingly water-soluble or water-insoluble organic active substance organic compounds are used which are used, for example, in the food and animal nutrition sector, for pharmaceutical and cosmetic applications, in the field of crop protection, in laundry detergents and cleaners, in textile care products or in the field of plastic additives ,
  • the sparingly water soluble or water insoluble organic active may also be an explosive, a wax or an insect repellent.
  • the microcapsules according to the invention can be used advantageously in all the applications in which the active ingredient is to be temporarily or permanently separated from the environment.
  • the organic agents are chemical compounds that usually contain both carbon and hydrogen.
  • a sparingly water-soluble organic active substance is usually a chemical compound whose solubility in water at 20 ° C. is less than 10 g / l, preferably less than 1 g / l, particularly preferably less than 0.1 g / l.
  • Active ingredients used in the food and animal nutrition sector include lipophilic vitamins such as tocopherol, vitamin A and its derivatives, vitamin D and its derivatives, vitamin K and its derivatives, vitamin F and its derivatives, or saturated and unsaturated fatty acids Derivatives and compounds thereof, natural and synthetic flavorings, flavors and fragrances and lipophilic dyes, such as retinoids, flavonoids or carotenoids.
  • lipophilic vitamins such as tocopherol, vitamin A and its derivatives, vitamin D and its derivatives, vitamin K and its derivatives, vitamin F and its derivatives, or saturated and unsaturated fatty acids Derivatives and compounds thereof, natural and synthetic flavorings, flavors and fragrances and lipophilic dyes, such as retinoids, flavonoids or carotenoids.
  • Active substances used in the pharmaceutical sector include anesthetics and narcotics, anticholinergics, antidepressants, psychostimulants and neuroleptics, antiepileptics, antimycotics, antiphlogistics, bronchodilators, cardiovascular drugs, cytostatics, hyperemics, lipid-lowering drugs, spasmolytics, testosterone derivatives, tranquilizers or antivirals.
  • Active ingredients used in the field of cosmetics include perfume oils, organic UV filters, dyes, organic pigments or care agents such as vitamin E acetate.
  • Preferred dyes which can be used as active ingredients in the microcapsules according to the invention are natural or synthetic dyes which are approved in the field of nutrition or cosmetics, as described, for example, in WO 2005/009604 A1 on page 9, lines 18 to 30 .
  • Crop protection agents are lipophilic agrochemicals such as insecticides, fungicides, pesticides, nematicides, rodenticides, molluscicides, growth regulators and herbicides.
  • pesticide denotes at least one active substance selected from the group of fungicides, insecticides, nematicides, herbicides, rodenticides, safeners and / or growth regulators.
  • Preferred pesticides are fungicides, insecticides, rodenticides and herbicides.
  • mixtures of pesticides Two or more of the above classes may be used.
  • Active ingredients which are used in the field of detergents and cleaners or textile care agents are, for example, flavorings or fragrances, disinfectants, dyes, bleaches, biocides, organic solvents or perfumes.
  • Active substances used in the field of plastic additives are, for example, light stabilizers, such as UV stabilizers, flame retardants or antioxidants.
  • the sparingly water-soluble or water-insoluble organic active substance which is contained in the core of the microcapsules according to the invention is preferably an aroma chemical, in particular a flavoring, fragrance or fragrance substance.
  • An aroma chemical in particular a fragrance or fragrance, is understood as meaning all organic substances which have a desired olfactory property and are substantially non-toxic. These include, among others, all fragrances or fragrances commonly used in detergent or cleaning compositions or in perfumery. It may be compounds of natural, semi-synthetic or synthetic origin. Preferred scents or fragrances can be assigned to the substance classes of hydrocarbons, aldehydes or esters. Fragrances also include natural extracts and / or essences which may contain complex mixtures of ingredients such as orange oil, lemon oil, rose extract, lavender, musk, patchouli, balsamic essence, sandalwood oil, pine oil and cedar oil.
  • Non-limiting examples of synthetic and semi-synthetic fragrances or fragrances are: 7-acetyl-1,2,3,4,5,6,7,8-octahydro-1, 1, 6,7-tetramethylnaphthalene, a-ionone, ⁇ -ionone, ⁇ -aminoethyl, ⁇ -isomethylionone, methyl cedryl ketone, methyl dihydrojasmonate, methyl-1, 6,10-trimethyl-2,5,9-cyclododecatriene-1-yl ketone, 7-acetyl-1, 1, 3,4,4,6-hexamethyl-tetralin, 4-acetyl-6-tert-butyl-1, 1-dimethylindane, hydroxyphenylbutanone, benzophenone, methyl- ⁇ -naphthyl ketone, 6-acetyl-1, 1, 2,3, 3,5-hexamethylindane, 5-acetyl-3-isopropyl-1,
  • fragrances or rich substances which can be used in the microcapsules according to the invention are described, for example, in US Pat. No. 6,143,707, US Pat. No. 5,089,162, EP 1 360 270, DE 10 2008 030 662, paragraphs 0025 to 0036 and WO 2009/027957.
  • a detailed description of the various most commonly used aroma chemicals which can also be used in the microcapsules of the present invention as a sparingly water-soluble or water-insoluble organic agent can be found in the book "Common Fragrance and Flavor Materials" by H. Surburg and J. Panten, 5. , completely. u. ext. Edition - February 2006, Wiley-VCH, Weinheim.
  • hexyl cinnamic aldehyde 2-methyl-3 - (- tert-butylphenyl) propionaldehyde, 7-acetyl-1,2,3,4,5,6,7,8-octahydro-1,1,6,7 tetramethylnaphthalene, benzyl salicylate, 7-acetyl-1,1,1,4,4,6-hexamethyl-tetralin, para-tert-butylcyclohexyl-acetate, methyl-dihydro-jasmonate, ⁇ -naphthol-methyl-ether, methyl- ⁇ naphthyl ketone, 2-methyl-2- (para-iso-propylphenyl) -propionaldehyde, 1, 3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-cyclopenta-Y 2-benzopyran, dodecahydro-3a, 6,6,9a-t
  • fragrances include essential oils, resinoids and resins from a variety of sources such as Peru balsam, Olibanum resinoid, Styrax, Labdanum resin, nutmeg, cassia oil, benzoin resin, coriander and lavandin.
  • suitable fragrances are: phenyl ethyl alcohol, terpineol, linalool, linalyl acetate, geraniol, nerol, 2- (1, 1 -dimethylethyl) - cyclohexanol acetate, benzyl acetate and eugenol.
  • fragrances or fragrances can be used as pure substances or mixed with one another.
  • the sparingly water-soluble or water-insoluble organic active ingredient preferably the Aromachemikalie, in particular the perfume or fragrance at 20 ° C, a liquid or a solid, wherein the solid itself in a suitable lipophilic solvent such as an oil, in dissolved form or may be present as a suspension.
  • a suitable lipophilic solvent such as an oil
  • the sparingly water-soluble or water-insoluble organic active substance used in the microcapsule according to the invention is preferably a liquid at 20 ° C.
  • this fragrance or fragrance another hydrophobic material can be added.
  • the sparingly water-soluble or water-insoluble organic active substance in particular the fragrance or fragrance or the mixture of fragrances or fragrances, constitutes from 1 to 100% by mass, preferably from 20 to 100% by mass, of the hydrophobic core material.
  • the hydrophobic material is liquid at temperatures below 100 ° C, preferably at temperatures below 60 ° C and most preferably at room temperature.
  • the core of the microcapsules according to the invention may also contain hydrophobic auxiliaries, such as oils or solvents, which are commonly used in the respective fields of application.
  • the hydrophobic excipients that can be used as part of the core of the microcapsule of the invention include all types of oils, such as vegetable oils, animal oils, mineral oils, paraffins, chloroparaffins, fluorocarbons, and other synthetic oils.
  • Typical and non-limiting examples are sunflower oil, rapeseed oil, olive oil, peanut oil, soybean oil, kerosene, benzene, toluene, butane, pentane, hexane, cyclohexane, chloroform, carbon tetrachloride, chlorinated diphenyls and silicone oil.
  • Hydrophobic high boiling point materials can also be used, e.g.
  • Typical oil components in cosmetics are, for example, paraffin oil, glyceryl stearate, isopropyl myristate, diisopropyl adipate, 2-ethylhexanoic acid cetylstearyl ester, hydrogenated polyisobutene, vaseline, caprylic acid / capric acid triglycerides, microcrystalline wax, lanolin and stearic acid.
  • this list is exemplary and not exhaustive.
  • the microcapsules according to the invention have a shell directly around the core.
  • This shell comprises at least one metal oxide and at least one water-soluble polymer.
  • the metal oxide of the shell is usually a metal oxide insoluble in water (pH 7).
  • the metal oxide of the shell is preferably such a metal oxide derived from a metal of which water-soluble, in particular readily soluble, salts of this metal are available in the oxidation state +11, +111 or + IV.
  • the metal is particularly preferably present in these salts as a double or triple charged cation.
  • readily soluble salts in water at 20 ° C. have a solubility of at least 10 g / l, preferably of at least 100 g / l, particularly preferably of at least 200 g / l.
  • the metal oxide of the shell is preferably an oxide of the metals zinc, cerium, zirconium, aluminum, magnesium, iron, manganese, nickel or cobalt. Particularly preferably, the metal oxide of the shell is zinc oxide.
  • the shell of the microcapsules according to the invention contains, in addition to the metal oxide, at least one water-soluble polymer.
  • water-soluble polymers are polyacrylates, polyaspartic acid, polyethers, polyvinylpyrrolidones and their corresponding copolymers.
  • the water-soluble polymer in the side chains preferably contains carboxy or carboxylate groups, for example in the case of polyacrylates or polyaspartic acid. Particularly preferred are polyacrylates.
  • the polyacrylates which are particularly preferred according to the invention are polymers based on at least one ⁇ , ⁇ -unsaturated carboxylic acid, for example acrylic acid, methacrylic acid, dimethacrylic acid, ethacrylic acid, maleic acid, citraconic acid, methylenemalonic acid, crotonic acid, isocrotonic acid, fumaric acid, mesaconic acid and itaconic acid.
  • polyacrylates based on acrylic acid, methacrylic acid, maleic acid or mixtures thereof are used.
  • the polyacrylates may contain other comonomers which are polymerized into the polymer chain, for example, the esters, amides and nitriles of the above-mentioned carboxylic acids, eg.
  • the molecular weight of the polyacrylates particularly preferred according to the invention is generally in the range of 800 to 250,000 g / mol, preferably in the range of 1,000 to 100,000 g / mol, particularly preferably in the range of 1,000 to 20,000 g / mol.
  • Another object of the present invention is also a process for producing microcapsules having a core-shell structure containing at least one low molecular weight, anionic surfactant, wherein each microcapsule inside a core containing at least one poorly water-soluble or water-insoluble organic active ingredient and directly around the core has a shell, the shell comprising at least one metal oxide and at least one water-soluble polymer, comprising the process steps
  • Preparation of an oil-in-water emulsion by emulsifying an oil phase which contains at least one sparingly water-soluble or water-insoluble organic active ingredient in a water phase containing at least one low molecular weight anionic surfactant and at least one water-soluble salt of a metal in the oxidation state + II, + III or + IV contains, using shear forces,
  • process step i) the preparation of an oil-in-water emulsion by emulsifying an oil phase containing at least one sparingly water-soluble or water-insoluble organic active ingredient in a water phase containing at least one low molecular weight, anionic surfactant and at least one water-soluble salt of a metal in the Oxidation state + II, + III or + IV, described using shear forces.
  • emulsions using shear forces are known in principle to the person skilled in the art.
  • Fantaschale and pestle fast stirrers, high pressure homogenizers, shakers, vibratory mixers, ultrasonic generators, emulsifying centrifuges, colloid mills or atomizers can be used to produce emulsions.
  • the person skilled in the art selects in each case the suitable method and the appropriate emulsifying tool as a function of the desired result, for example the desired droplet size in the emulsion, and depending on the physicochemical properties of the chosen starting materials, for example their viscosity or their thermal stability.
  • the proportion of the oil phase in the emulsion is preferably from 1 to 50% by weight, particularly preferably from 10 to 40% by weight, based on the total mass of the emulsion.
  • the proportion by weight of the surfactants used in process step i), based on the mass of the oil phase is preferably in the range from 0.5% to 20%, in particular in the range from 1% to 5%.
  • the water-soluble salt of a metal used in process step i) in the oxidation state + II, + III or + IV, in particular the oxidation state + II or + III is preferably a salt of said oxidation states which is readily soluble in water.
  • preferred salts are, for example, the halides, acetates or nitrates of the metals zinc, cerium, tin, aluminum, magnesium, iron, manganese, nickel or cobalt, in particular of zinc.
  • Particular preference is given in step i) to use as the water-soluble salt zinc chloride, zinc nitrate or zinc acetate.
  • the concentration of the water-soluble salt of a metal used in the oxidation state + II, + III or + IV in the water phase is generally in the range from 0.05 to 1 mol / l, preferably in the range from 0.1 to 0.5 mol / l, more preferably in the range of 0.2 to 0.4 mol / l.
  • the molar ratio between the low molecular weight anionic surfactant and the water-soluble salt of a metal in the oxidation state + II, + III or + IV is preferably in the range from 1:10 to 1: 1, preferably in the range from 1: 8 to 1: 3.
  • process step ii) the oil prepared in process step i) is washed in water emulsion for the removal of water-free dissolved salt and anionic surfactant until the aqueous phase has a conductivity of less than 2.0 mS / cm.
  • Process step ii) can be realized by centrifuging, filtering, evaporating the solvents, re-suspending and dialysis processes. Particularly preferred in the inventive method as a filtration method, a cross-flow filtration is performed.
  • the emulsion is washed until the aqueous phase has a conductivity of less than 2.0 mS / cm, preferably a conductivity in the range of 0.1 to 0.5 mS / cm.
  • the measurement of the conductivity is known to the person skilled in the art and can be carried out directly in the emulsion to be cleaned with a commercially available conductivity meter.
  • process step iii) by adding an aqueous solution containing a strong base and a water-soluble polymer to the emulsion washed in process step ii) solid metal oxide at the oil phase boundary of the water-soluble salt of the metal in the oxidation state + II, + III or + IV, which is bound in the region of the oil-water phase boundary produced.
  • the strong bases to be used according to the invention may generally be any substances capable of having a pH in aqueous solution of from about 8 to about 13, preferably about, depending on their concentration 9 to produce about 12.5. These may be, for example, metal oxides or hydroxides as well as ammonia or amines.
  • alkali metal hydroxides such as sodium or potassium hydroxide
  • alkaline earth metal hydroxides such as calcium hydroxide or ammonia
  • sodium hydroxide, potassium hydroxide or ammonia in particular sodium hydroxide, as the strong base.
  • the concentration of the strong base in the aqueous solution, which is added in process step iii) to the emulsion washed in process step ii), is generally selected such that in the aqueous solution a hydroxide ion concentration in the range of 0 , 1 to 2 mol / l, more preferably from 0.2 to 1 mol / l and in particular from 0.4 to 0.8 mol / l.
  • the molar amount of hydroxide ions in the aqueous solution is preferably chosen such that, at least theoretically, the metal ions of the metal present in the emulsion in the oxidation state + II, + III or + IV after the end of the addition of the aqueous solution are completely in the form of the corresponding hydroxides M (OH ) 2, M (OH) 3 or M (OH) 4 could be present.
  • the concentration of the water-soluble polymer, in particular of the polyacrylates in the aqueous solution, which is added in process step iii) to the emulsion washed in process step ii) is generally in the range from 0.1 to 20 g / l, preferably in the range from 1 to 10 g / l, more preferably in the range of 1, 5 to 5 g / l.
  • the water-soluble polymers used according to the invention must have a corresponding water solubility.
  • a preferred embodiment of the process according to the invention is characterized in that the precipitation of the metal oxide, metal hydroxide and / or the metal oxide hydroxide and production of the solid metal oxide takes place in the presence of a polyacrylate, which is obtained from pure acrylic acid.
  • a polyacrylate which is obtained from pure acrylic acid.
  • Sokalan ® PA 15 from BASF SE
  • the sodium salt of a polyacrylic acid Mn: about 1200 g / mol; pH: 8; K-value according to ISO 1628 -1, 1% in distilled water: about 15).
  • aqueous solution containing the strong base and the water-soluble polymer to the emulsion washed in process step ii) is usually carried out at a temperature in the range of 0 to 100 ° C, preferably 10 to 60 ° C, especially 30 to 45 ° C performed.
  • the addition of the aqueous solution, which contains the strong base and the water-soluble polymer, to the washed emulsion can, in principle, be carried out at any speed. Preferably, the addition is made evenly distributed in more than 30 minutes. Particularly preferred in step iii) the addition of the aqueous solution containing a strong base and a water-soluble polymer, evenly distributed over a period of 2 to 5 hours made.
  • the water-soluble polymer serves to accelerate the dehydration of the primarily formed metal hydroxide to the metal oxide.
  • the calcination process frequently used in the conversion of metal hydroxides into the corresponding metal oxides at temperatures above 100 ° C. can be dispensed with in the present process.
  • the suspension of microcapsules formed in process step iii) can be additionally stabilized by addition of further additives, such as nonionic, anionic or cationic polymers or surfactants.
  • the microcapsules with core-shell structure produced in process step iii) can be further purified and / or isolated in a subsequent process step iv).
  • the person skilled in the art is aware of appropriate purification and isolation processes, such as, for example, centrifuging, filtering, evaporation of the solvents, re-suspending and dialysis processes.
  • removing the solvents in particular by removing the water, for example in a spray-drying process, a powder can be obtained from the aqueous suspension of the microcapsules.
  • microcapsules according to the invention with a core-shell structure are suitable according to the encapsulated active ingredient as an additive to detergents and cleaners, fabric care products, cosmetics, pharmaceutical agents, crop protection compositions, plastics, animal feeds, foods or food supplements.
  • Another object of the present invention is the use of the microcapsules with a core-shell structure described above or which were prepared by the method described above, as an additive to detergents and cleaners, fabric care products, cosmetics, pharmaceutical agents, pesticide preparations, plastics , Animal feed, food or nutritional supplements.
  • Another object of the present invention are powdered or liquid preparations comprising the above-described microcapsules having a core-shell structure or which have been prepared by the method described above.
  • the pulverulent or liquid preparations usually contain at least one of the customary additives and / or adjuvants which are suitable for the respective field of application, for example in the field of detergents and cleaners, fabric care products, cosmetics, Pharmaceutical agents, crop protection preparations, plastics, animal feed, food or dietary supplements are known.
  • pulverulent or liquid preparations as an additive to detergents and cleaners, fabric care products, cosmetics, pharmaceutical agents, crop protection compositions, plastics, animal feeds, foods or food supplements.
  • Another object of the present invention are detergents and cleaners, fabric care products, cosmetics, pharmaceutical compositions, crop protection compositions, plastics, animal feed, food or dietary supplements containing the microcapsules according to the invention with a core-shell structure described above or according to the previously described methods were prepared.
  • citronellylnitrile (BASF SE) were dissolved at room temperature (20 ° C) in a mixture of 7.5 g of paraffin oil and 2.5 g of glycerol monooleate (Mazol PGO ® 31 K of BASF Corporation).
  • 4 g of polyoxyethylene (20) sorbitan monolaurate (polysorbate 20, commercially available under Tween ® 20) were alkylphenol ether sulfate and 4 g (Lutensit ® A-ES from BASF SE) in 150 g of a 0.5 molar aqueous solution of zinc chloride solved.
  • the oil phase was homogenized with the water phase with the aid of an ultrasonic rod (sonotrode 14 mm) for 3 minutes.
  • the emulsion was stirred for 2 hours at room temperature to complete the formation of the zinc ion hydration vials around the oil droplets. Free salt and excess surfactant were washed out of the emulsion by cross-flow filtration until an emulsion conductivity value of 0.5 mS / cm was reached. (BASF SE, Sokalan ® PA 15) in a concentration of 5 g / l 75 ml of a 1 molar aqueous solution of NaOH, the polyacrylic acid sodium salt, was slowly added (0.5 ml / min) to the washed emulsion, to start the formation of zinc oxide on the surface of the oil droplets. After completion of the addition of NaOH and Polyacrylic acid-sodium salt-containing solution, the suspension formed at 40 ° C for 5 h was further stirred with a magnetic stirrer to age the zinc oxide shells.
  • BASF SE Sokalan ® PA 15
  • the particle size distribution of the microcapsules formed was determined by means of light scattering in accordance with ISO 13320-1 (Microtrac S3500 Bluewave from Microtrac):
  • the theoretical loading of the microcapsules with citronellylnitrile is about 45% by weight, based on the mass of the microcapsules.
  • the actual loading of the microcapsules was determined by thermogravimetry (TGA).
  • TGA thermogravimetry
  • the weight loss of a dried at 300 ° C sample compared to the spray-dried at 130 ° C starting sample is about 30%. This means that the loading of the microcapsules is at least 30% by weight, based on the mass of the microcapsules.
  • Example 2 Encapsulation of linalyl acetate (CAS Reg. No. 1 15-95-7) with zinc oxide
  • Free salt and excess surfactant were washed out of the emulsion by means of cross-flow filtration until a value for the conductivity of the emulsion of 0.5 mS / cm was reached.
  • the resulting suspension was further stirred at 40 ° C for 5 hours with a magnetic stirrer to age the zinc oxide dishes.
  • the particle size distribution of the microcapsules formed was determined by means of light scattering in accordance with ISO 13320-1 (Microtrac S3500 Bluewave from Microtrac):
  • the emulsion was stirred for 2 hours at 40 ° C to complete the formation of the zinc ion hydrate shells around the oil droplets. Free salt and excess surfactant were washed out of the emulsion by cross-flow filtration until an emulsion conductivity value of 0.5 mS / cm was reached. 30 ml of a 1 molar aqueous solution of NaOH containing polyaspartic acid at a concentration of 5 g / l was added to the washed emulsion at a flow rate of 0.5 ml / min to prevent the formation of zinc oxide on the surface of the To start oil droplets. After completion of the addition of the NaOH and polyaspartic acid-containing solution, the resulting suspension was further stirred at 40 ° C for 8 hours with a magnetic stirrer to age the zinc oxide shells.
  • the particle size distribution of the microcapsules formed was determined by means of light scattering in accordance with ISO 13320-1 (Microtrac S3500 Bluewave from Microtrac):

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Toxicology (AREA)
  • Textile Engineering (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

La présente invention concerne des microcapsules à structure coeur-enveloppe contenant au moins un tensio-actif anionique à bas poids moléculaire et présentant une enveloppe qui contient de l'oxyde métallique. L'invention a également pour objet un procédé pour réaliser de telles microcapsules à structure coeur-enveloppe, l'utilisation des microcapsules à structure coeur-enveloppe, et des préparations contenant les microcapsules à structure coeur-enveloppe.
PCT/EP2011/059423 2010-06-09 2011-06-08 Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique WO2011154421A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10165347 2010-06-09
EP10165347.5 2010-06-09

Publications (1)

Publication Number Publication Date
WO2011154421A1 true WO2011154421A1 (fr) 2011-12-15

Family

ID=44627573

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/059423 WO2011154421A1 (fr) 2010-06-09 2011-06-08 Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique

Country Status (1)

Country Link
WO (1) WO2011154421A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446627B2 (en) 2019-04-17 2022-09-20 The Procter & Gamble Company Capsules
US11628413B2 (en) 2019-04-17 2023-04-18 The Procter & Gamble Company Methods of making capsules
US11904287B2 (en) 2019-04-17 2024-02-20 The Procter & Gamble Company Capsules
US11912961B2 (en) 2020-10-16 2024-02-27 The Procter & Gamble Company Liquid fabric care compositions comprising capsules
US11938349B2 (en) 2020-10-16 2024-03-26 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising capsules

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089162A (en) 1989-05-08 1992-02-18 Lever Brothers Company, Division Of Conopco, Inc. Cleaning compositions with bleach-stable colorant
US6143707A (en) 1996-03-19 2000-11-07 The Procter & Gamble Company Built automatic dishwashing compositions comprising blooming perfume
WO2001080823A2 (fr) * 2000-04-21 2001-11-01 Sol-Gel Technologies Ltd. Composition a stabilite de preparation accrue et administration d'ingredients actifs topiques
US20020064541A1 (en) * 2000-04-21 2002-05-30 Noa Lapidot Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1360270A2 (fr) 2001-02-14 2003-11-12 The Procter & Gamble Company Compositions pour lave-vaisselle automatique contenant un parfum de fleurs et des ingredients de masquage de base
WO2005009604A1 (fr) 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules chargees d'ingredients actifs et procede de preparation
WO2007015243A2 (fr) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Revetement par un oxyde metallique d'ingredients hydroinsolubles
WO2008072239A2 (fr) * 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation de particules cœur-enveloppe nanométriques comportant une enveloppe d'oxyde métallique
WO2008093346A2 (fr) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions d'application topique comprenant un peroxyde et un rétinoïde
WO2008093347A2 (fr) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Méthode de préparation de particules comprenant un enrobage d'oxyde métallique, et particules enrobées d'oxyde métallique
WO2009027957A2 (fr) 2008-12-16 2009-03-05 The Procter & Gamble Company Systèmes de parfums
WO2009090169A1 (fr) 2008-01-15 2009-07-23 Basf Se Microcapsules contenant un parfum et à comportement de libération amélioré
DE102008030662A1 (de) 2008-07-01 2010-01-07 Henkel Ag & Co. Kgaa Beschichtete Partikel für den Einsatz in Kosmetika

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089162A (en) 1989-05-08 1992-02-18 Lever Brothers Company, Division Of Conopco, Inc. Cleaning compositions with bleach-stable colorant
US6143707A (en) 1996-03-19 2000-11-07 The Procter & Gamble Company Built automatic dishwashing compositions comprising blooming perfume
WO2001080823A2 (fr) * 2000-04-21 2001-11-01 Sol-Gel Technologies Ltd. Composition a stabilite de preparation accrue et administration d'ingredients actifs topiques
US20020064541A1 (en) * 2000-04-21 2002-05-30 Noa Lapidot Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1360270A2 (fr) 2001-02-14 2003-11-12 The Procter & Gamble Company Compositions pour lave-vaisselle automatique contenant un parfum de fleurs et des ingredients de masquage de base
WO2003034979A2 (fr) * 2001-10-23 2003-05-01 Sol-Gel Technologies Ltd. Composition amelioree en terme de stabilite de preparation et de diffusion topique des principes actifs
WO2005009604A1 (fr) 2003-07-31 2005-02-03 Sol-Gel Technologies Ltd. Microcapsules chargees d'ingredients actifs et procede de preparation
WO2007015243A2 (fr) 2005-08-02 2007-02-08 Sol-Gel Technologies Ltd. Revetement par un oxyde metallique d'ingredients hydroinsolubles
WO2008072239A2 (fr) * 2006-12-12 2008-06-19 Sol-Gel Technologies Ltd. Formation de particules cœur-enveloppe nanométriques comportant une enveloppe d'oxyde métallique
WO2008093346A2 (fr) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Compositions d'application topique comprenant un peroxyde et un rétinoïde
WO2008093347A2 (fr) * 2007-02-01 2008-08-07 Sol-Gel Technologies Ltd. Méthode de préparation de particules comprenant un enrobage d'oxyde métallique, et particules enrobées d'oxyde métallique
WO2009090169A1 (fr) 2008-01-15 2009-07-23 Basf Se Microcapsules contenant un parfum et à comportement de libération amélioré
DE102008030662A1 (de) 2008-07-01 2010-01-07 Henkel Ag & Co. Kgaa Beschichtete Partikel für den Einsatz in Kosmetika
WO2009027957A2 (fr) 2008-12-16 2009-03-05 The Procter & Gamble Company Systèmes de parfums

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Pesticide Manual", 2006, THE BRITISH CROP PROTECTION COUNCIL
H. SURBURG, J. PANTEN: "Common Fragrance and Flavor Materials", February 2006, WILEY-VCH

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11446627B2 (en) 2019-04-17 2022-09-20 The Procter & Gamble Company Capsules
US11628413B2 (en) 2019-04-17 2023-04-18 The Procter & Gamble Company Methods of making capsules
US11904287B2 (en) 2019-04-17 2024-02-20 The Procter & Gamble Company Capsules
US11912961B2 (en) 2020-10-16 2024-02-27 The Procter & Gamble Company Liquid fabric care compositions comprising capsules
US11938349B2 (en) 2020-10-16 2024-03-26 The Procter & Gamble Company Antiperspirant and deodorant compositions comprising capsules

Similar Documents

Publication Publication Date Title
EP2237874B1 (fr) Microcapsules contenant un parfum et à comportement de libération amélioré
DE60224365T2 (de) System mit kontrollierter abgabe für haarpflegemittel
KR101457287B1 (ko) 활성 성분을 포함하는 캡슐
WO2010119020A1 (fr) Système support pour parfums
WO2011154421A1 (fr) Microcapsules contenant du principe actif et présentant une enveloppe qui contient de l'oxyde métallique
EP2240267B1 (fr) Microcapsules comprenant un agent tensioactif lipophile et de l'huile
EP2614134B1 (fr) Détergents ou produits de nettoyage contenant des microcapsules
WO2010003762A1 (fr) Particules contenant une substance active
WO2003045545A1 (fr) Capsules de gel contenant des agents actifs et utilisation
DE102011082496A1 (de) Mikrokapselhaltiges Mittel
KR20030048122A (ko) 코어-쉘 입자 및 이의 제조방법
US11224569B2 (en) Hydrogel capsules and process for preparing the same
WO2005097197A1 (fr) Particules polymeres contenant des agents actifs
US20110306501A1 (en) Active ingredient-comprising microcapsules with a metal oxide-containing shell
EP2295044A1 (fr) Encapsulage en utilisant des substances de type cire
WO2014041001A1 (fr) Procede alternatif de microencapsulation de principes actifs
EP0912094A1 (fr) Nouvelles formulations insecticides
CN111655220A (zh) 用于延迟递送香料的泡囊、它们的制备及其用途
JP2021183322A (ja) マイクロカプセル及びその製造方法
CN109966174B (zh) 一种胶囊分散体的制备方法及其应用
DE102013217239A1 (de) Emulgatorfreie, hautkonditionierende kosmetische oder dermatologische Zubereitung mit Repellentien
EP2217362A2 (fr) Microparticules encapsulées présentant un noyau qui contient des virus, et procédé de préparation des microparticules
KR20190026816A (ko) 약제학적 조성물
DE69814061T2 (de) Verfahren zur herstellung von emulgiertem puder
DE19603453C1 (de) Mikropartikel, enthaltend einen Wirkstoff und ein polymeres Kapselwandmaterial, ein Verfahren zu deren Herstellung und deren Verwendung

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11727943

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11727943

Country of ref document: EP

Kind code of ref document: A1